Is Reta Safe for Women? What to Know About Retatrutide

Retatrutide (often called 'reta') is not FDA-approved for human use, so there is no established safety profile for women. Early clinical trials show meaningful weight loss, but they also report gastrointestinal side effects, heart rate increases, and other risks that make medical supervision essential. For women who are pregnant, breastfeeding, or trying to conceive, retatrutide is not considered safe.

What Is Retatrutide (Reta)?

Retatrutide is an investigational triple agonist peptide. It targets three hormone receptors: GLP-1, GIP, and glucagon. This combination is designed to reduce appetite, improve blood sugar control, and increase energy expenditure.

Unlike semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), retatrutide is still in phase 3 trials. That means researchers have not finished evaluating its long-term safety. If you are asking what is reta for fat loss, it is being studied as a once-weekly injection for obesity and type 2 diabetes.

Is Reta Safe for Women? What the Research Shows

There is no simple yes or no answer. In clinical trials, women have received retatrutide, and the drug has produced weight loss in both sexes. However, safety data specific to women are limited because trials often combine male and female participants in their primary analyses.

What we do know:

• Gastrointestinal side effects are common. Nausea, vomiting, diarrhea, and constipation are the most frequently reported issues. In some GLP-1 studies, women report these effects at higher rates than men.
• Heart rate can increase. Retatrutide has been linked to a modest rise in resting heart rate. This matters more for women with existing heart conditions.
• Gallbladder and pancreas risks exist. GLP-1 class drugs can cause gallbladder disease and, rarely, pancreatitis.
• Pregnancy is a hard stop. Animal studies suggest potential harm to a fetus. Women who are pregnant, planning pregnancy, or breastfeeding should not use retatrutide.

In a phase 2 trial published in the New England Journal of Medicine, participants taking retatrutide lost up to 24% of their body weight over 48 weeks. The trial included women, but it was not designed to detect sex-specific safety signals.

Retatrutide is not FDA-approved for human use in the United States, and its long-term safety in women is unknown.

Possible Side Effects Women Report

Common side effects from retatrutide trials include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Injection site reactions
• Fatigue
• Headache
• Increased heart rate

Less common but serious risks:

• Pancreatitis
• Gallbladder problems
• Kidney injury from dehydration
• Severe allergic reactions
• Thyroid C-cell tumors (seen in rodents; unknown in humans)

Nausea was the most common side effect, affecting about 40% of participants in some dose groups. Most cases were mild to moderate, but some women discontinued treatment.

Women may also notice changes in menstrual cycles in online anecdotes, but no large trial has confirmed a direct link. Because retatrutide slows gastric emptying, it could affect how oral medications—including birth control pills—are absorbed. Ask your clinician about backup contraception if you use oral contraceptives.

How Reta Compares With Other Weight Loss Options

If you are weighing is reta or tirz better for weight loss, know that tirzepatide is approved and retatrutide is not. The table below summarizes the current landscape.

This table is not a recommendation. The best option depends on your health history, goals, and tolerance. If you are wondering is tirz safe for weight loss, tirzepatide has a larger safety database and is FDA-approved for chronic weight management in eligible adults, including women.

Who Should Not Use Retatrutide

Retatrutide is not appropriate for everyone. You should avoid it if you:

• Are pregnant, breastfeeding, or trying to become pregnant
• Have a personal or family history of medullary thyroid cancer or MEN2
• Have had pancreatitis
• Have severe kidney or liver disease
• Have a history of gallbladder disease
• Take medications that interact with gastric emptying

Women with a history of eating disorders should also be cautious, as weight loss medications can worsen disordered eating patterns.

Even if none of these apply, using an unapproved peptide from a gray-market vendor carries extra risks: no dosing standards, no purity guarantees, and no medical oversight. Retatrutide is not a safe DIY weight loss solution for women.

Other Peptides Women Often Ask About

Women researching retatrutide often look into other peptides too. For example, many ask is bpc-157 safe for women for recovery or gut health, or is sermorelin good for women for sleep and hormone support. Neither is FDA-approved for general use, and both carry their own unknowns.

If you are considering any peptide, start with a licensed healthcare provider who knows your history. They can help you separate evidence from hype and monitor for side effects.

Bottom Line

Retatrutide is not safe for women to use outside of a clinical trial. It is unapproved, its long-term effects are unknown, and it carries real risks—especially during pregnancy. If you are seeking weight loss help, talk to a doctor about approved options like tirzepatide or semaglutide, lifestyle changes, and other evidence-based treatments.

Safety comes first: no online vendor or influencer can replace personalized medical advice.